Ishares Genomics Immunology Etf Buy Hold or Sell Recommendation
| IDNA Etf | USD 22.80 0.07 0.31% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding iShares Genomics Immunology is 'Hold'. Macroaxis provides IShares Genomics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IDNA positions.
Check out IShares Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual funds such as IShares and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
IShares |
Execute IShares Genomics Buy or Sell Advice
The IShares recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on iShares Genomics Immunology. Macroaxis does not own or have any residual interests in iShares Genomics Immunology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IShares Genomics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details |
IShares Genomics Trading Alerts and Improvement Suggestions
| iShares Genomics Imm generated a negative expected return over the last 90 days | |
| iShares Genomics Imm created five year return of -3.0% | |
| This fund retains 99.56% of its assets under management (AUM) in equities |
IShares Genomics Returns Distribution Density
The distribution of IShares Genomics' historical returns is an attempt to chart the uncertainty of IShares Genomics' future price movements. The chart of the probability distribution of IShares Genomics daily returns describes the distribution of returns around its average expected value. We use iShares Genomics Immunology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IShares Genomics returns is essential to provide solid investment advice for IShares Genomics.
| Mean Return | -0.05 | Value At Risk | -2.79 | Potential Upside | 1.95 | Standard Deviation | 1.42 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IShares Genomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IShares Genomics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IShares Genomics or iShares sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IShares Genomics' price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IShares etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 1.44 | |
Ir | Information ratio | -0.11 |
IShares Genomics Volatility Alert
iShares Genomics Immunology exhibits very low volatility with skewness of -0.78 and kurtosis of 0.39. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IShares Genomics' etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IShares Genomics' etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IShares Genomics Fundamentals Vs Peers
Comparing IShares Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IShares Genomics' direct or indirect competition across all of the common fundamentals between IShares Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as IShares Genomics or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of IShares Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing IShares Genomics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IShares Genomics to competition |
| Fundamentals | IShares Genomics | Peer Average |
| Beta | 1.21 | |
| One Year Return | 2.30 % | (0.97) % |
| Three Year Return | (12.20) % | 3.23 % |
| Five Year Return | (3.50) % | 1.12 % |
| Net Asset | 170.27 M | 2.29 B |
| Last Dividend Paid | 0.24 | 0.14 |
| Equity Positions Weight | 99.56 % | 52.82 % |
IShares Genomics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IShares . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 22.8 | |||
| Day Typical Price | 22.8 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) |
About IShares Genomics Buy or Sell Advice
When is the right time to buy or sell iShares Genomics Immunology? Buying financial instruments such as IShares Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having IShares Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Check out IShares Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.